NEW YORK (GenomeWeb News) — Nanotechnology shop Lumera has spun out a company that will compete in the proteomics tools market, Lumera said yesterday.

 

The company, Plexera Bioscience, has become a wholly owned subsidiary of Lumera and will serve as the operations unit of Lumera's bioscience business that it started in 2006.

 

Plexera will focus on providing “tools, content, and methods to simplify and accelerate proteomic discovery for therapeutic antibodies as well as predictive biomarkers,” Lumera said.